OKYO Pharma Today Announces Director Acquires Shares
March 29, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Announces PDMR Dealing
March 24, 2023 03:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
ImCheck Appoints Thomas Civik as Independent Chairman of the Board
March 23, 2023 03:00 ET
|
ImCheck Therapeutics SAS
ImCheck Appoints Thomas Civik as Independent Chairman of the Board Marseille, France, March 23, 2023 – ImCheck Therapeutics announced today the appointment of Thomas Civik as independent...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 21, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 20, 2023 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 17, 2023 08:10 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland
March 13, 2023 07:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland
March 13, 2023 02:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
TOP RANKED ROSEN LAW FIRM Encourages World Wrestling Entertainment, Inc. Investors to Inquire About Securities Class Action Investigation – WWE
February 18, 2023 18:05 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of World...
Cemtrex Reports First Quarter 2023 Financial Results
February 14, 2023 16:15 ET
|
Cemtrex Inc.
Gross Margin up 790 basis points to 42% in Q1’23 Management to Host Conference Call Today at 5:00 p.m. Eastern Time Brooklyn, NY, Feb. 14, 2023 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ:...